SFM
RDHL

Sphera Funds Management’s Redhill Biopharma RDHL Stock Holding History

Sphera Funds Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,715
Closed -$2.43M – 121
2014
Q1 		$2.43M Buy
+1,715
New +$23M 0.55% 36

Other funds holding RDHL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sphera Funds Management's RDHL Position: Q2 2014 in Review

Sphera Funds Management sold out of Redhill Biopharma (RDHL) in Q2 2014, closing a stake of 1,715 shares — an estimated $2.43M sold.

Sphera Funds Management first reported a position in RDHL in Q1 2014 and held it in 1 quarter. The position peaked at $2.43M in Q1 2014. 7 funds tracked by Wall St. Rank hold RDHL as of Q2 2014.

  • Sphera Funds Management reported no remaining Redhill Biopharma position as of Q2 2014 after selling out during the quarter.
  • Sphera Funds Management sold 1,715 Redhill Biopharma shares in Q2 2014, an estimated $2.43M.
  • Sphera Funds Management first reported a position in Redhill Biopharma in Q1 2014 and held it in 1 quarter.
  • Sphera Funds Management's Redhill Biopharma position peaked at $2.43M in Q1 2014.
  • 7 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2014.

Based on Sphera Funds Management's 13F filing for Q2 2014, filed 11 Aug 2014.